JPH11155520A - Use for sweetening, etc. or sweetening, etc., and foods and drinks or drugs with sweetening, etc. - Google Patents
Use for sweetening, etc. or sweetening, etc., and foods and drinks or drugs with sweetening, etc.Info
- Publication number
- JPH11155520A JPH11155520A JP10013238A JP1323898A JPH11155520A JP H11155520 A JPH11155520 A JP H11155520A JP 10013238 A JP10013238 A JP 10013238A JP 1323898 A JP1323898 A JP 1323898A JP H11155520 A JPH11155520 A JP H11155520A
- Authority
- JP
- Japan
- Prior art keywords
- dfa
- sweetness
- sugar content
- sweetener
- foods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title claims abstract description 14
- 235000000346 sugar Nutrition 0.000 claims abstract description 41
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 37
- 239000003765 sweetening agent Substances 0.000 claims abstract description 37
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 235000019605 sweet taste sensations Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 23
- 150000001720 carbohydrates Chemical class 0.000 abstract description 15
- 239000003623 enhancer Substances 0.000 abstract description 9
- 235000014633 carbohydrates Nutrition 0.000 abstract description 7
- 206010012735 Diarrhoea Diseases 0.000 abstract description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 13
- 229930006000 Sucrose Natural products 0.000 description 13
- 239000005720 sucrose Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- PBWZKZYHONABLN-UHFFFAOYSA-N difluoroacetic acid Chemical compound OC(=O)C(F)F PBWZKZYHONABLN-UHFFFAOYSA-N 0.000 description 9
- 239000006188 syrup Substances 0.000 description 9
- 235000020357 syrup Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 239000005715 Fructose Substances 0.000 description 7
- 229930091371 Fructose Natural products 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 229960002737 fructose Drugs 0.000 description 7
- 239000000845 maltitol Substances 0.000 description 7
- 235000010449 maltitol Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 210000000813 small intestine Anatomy 0.000 description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 6
- 229940035436 maltitol Drugs 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- LKDRXBCSQODPBY-ARQDHWQXSA-N beta-D-fructopyranose Chemical compound OC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ARQDHWQXSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000012970 cakes Nutrition 0.000 description 3
- 102000038379 digestive enzymes Human genes 0.000 description 3
- 108091007734 digestive enzymes Proteins 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000000077 insect repellent Substances 0.000 description 3
- 230000002475 laxative effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 150000002772 monosaccharides Chemical group 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 235000021110 pickles Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- RFSUNEUAIZKAJO-ZXXMMSQZSA-N alpha-D-fructofuranose Chemical compound OC[C@H]1O[C@@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ZXXMMSQZSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101710165037 Alpha-amylase 1 Proteins 0.000 description 1
- 102100033770 Alpha-amylase 1C Human genes 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- -1 Disaccharide sugar alcohols Chemical class 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000021549 curry roux Nutrition 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- KSRQDWNGXKYIDO-UHFFFAOYSA-N difructose anhydride III Natural products O1C2C(O)C(CO)OC2(CO)OCC21OC(CO)C(O)C2O KSRQDWNGXKYIDO-UHFFFAOYSA-N 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000011150 reinforced concrete Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 229940119265 sepp Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Seasonings (AREA)
Abstract
(57)【要約】
【課題】 ノンカロリーであるかカロリーがゼロに近
く、非還元性で安定性に優れ、水に対する溶解度が高
く、甘味度が低く、下痢を引き起こしにくい糖質を含有
する甘味剤等の提供。
【解決手段】 ジ−β−D−フラクトフラノース1,2
´:2,1´ジアンヒドリド(以下、β−DFAとい
う)を有効成分として含有する甘味剤もしくは糖含量上
昇剤、飲食品または薬品への甘味付与または糖含量上昇
のためのβ−DFAの使用、およびβ−DFAを含有さ
せることにより甘味を付与したまたは糖含量を上昇させ
た飲食品または薬品。(57) [Summary] [Problems] Non-caloric or near zero calorie, non-reducing and excellent in stability, high solubility in water, low sweetness, and sweetness containing carbohydrate which does not easily cause diarrhea Provision of agents and the like. SOLUTION: Di-β-D-fructofuranose 1,2
': Sweetener or sugar content enhancer containing 2,1' dianhydride (hereinafter referred to as β-DFA) as an active ingredient, use of β-DFA for imparting sweetness to foods, drinks or medicines or increasing sugar content. And foods and drinks or medicines which are sweetened or have an increased sugar content by containing β-DFA.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、特に食品分野およ
び薬品分野において利用し得る、特定糖質を含有する甘
味剤等もしくはその甘味付与等のための使用、および該
特定糖質により甘味付与等した飲食品もしくは薬品に関
する。[0001] The present invention relates to a sweetener containing a specific saccharide, its use for imparting sweetness, etc., which can be used particularly in the food and pharmaceutical fields, and the use of the specific saccharide to impart sweetness, etc. Related to food and drink or medicines.
【0002】[0002]
【従来の技術】従来、ジフラクトースジアンヒドリド
(以下、DFAという)類としては、DFAI(α−D
−フラクトフラノースβ−D−フラクトフラノース1,
2´:2,1´ジアンヒドリド)、DFAII(β−D
−フラクトフラノースβ−D−フラクトフラノース1,
2´:2,3´ジアンヒドリド)、DFAIII(α−
D−フラクトフラノースβ−D−フラクトフラノース
1,2´:2,3´ジアンヒドリド)、DFAIV(β
−D−フラクトフラノースβ−D−フラクトフラノース
2,6´:6,2´ジアンヒドリド)、ジヘテロレブロ
サンI(α−D−フラクトピラノースβ−D−フラクト
ピラノース1,2´:2,1´ジアンヒドリド)、ジヘ
テロレブロサンII(α−D−フラクトフラノースβ−
D−フラクトピラノース1,2´:2,1´ジアンヒド
リド)、ジヘテロレブロサンIII(β−D−フラクト
フラノースβ−D−フラクトピラノース1,2´:2,
1´ジアンヒドリド)、ジヘテロレブロサンIV(β−
D−フラクトピラノースβ−D−フラクトピラノース
1,2´:2,1´ジアンヒドリド)などが知られてい
る(Nippon Nogeikagaku Kais
hi 63(1989),1136−1140、 C
arbohydrate Research, 136
(1985), 53−65)。2. Description of the Related Art Hitherto, difructose dianhydride (hereinafter referred to as DFA) has been known as DFAI (α-D
-Fructofuranose β-D-Fructofuranose 1,
2 ′: 2,1 ′ dianhydride), DFAII (β-D
-Fructofuranose β-D-Fructofuranose 1,
2 ': 2,3' dianhydride), DFAIII (α-
D-fructofuranose β-D-fructofuranose 1,2 ′: 2,3 ′ dianhydride), DFAIV (β
-D-fructofuranose β-D-fructofuranose 2,6 ′: 6,2 ′ dianhydride), diheterolebrosan I (α-D-fructopyranose β-D-fructopyranose 1,2 ′: 2,1) 'Dianhydride), diheterolebrosan II (α-D-fructofuranose β-
D-fructopyranose 1,2 ′: 2,1 ′ dianhydride), diheterolebrosan III (β-D-fructofuranose β-D-fructopyranose 1,2 ′: 2)
1 'dianhydride), diheterolebrosan IV (β-
D-fructopyranose β-D-fructopyranose 1,2 ′: 2,1 ′ dianhydride) and the like are known (Nippon Nogeikagaku Kais).
hi 63 (1989), 1136-1140, C
arbohydrate Research, 136
(1985), 53-65).
【0003】また、ジ−α−D−フラクトフラノース
1,2´:2,1´ジアンヒドリド(α−DFA)およ
びジ−β−D−フラクトフラノース1,2´:2,1´
ジアンヒドリド(β−DFA)がCarbohydra
te Research, 287(1996),18
3−202にそれぞれ化合物番号10および15として
記載されている。Also, di-α-D-fructofuranose 1,2 ′: 2,1 ′ dianhydride (α-DFA) and di-β-D-fructofuranose 1,2 ′: 2,1 ′
Dianhydride (β-DFA) is Carbohydra
te Research, 287 (1996), 18
3-202 describe Compound Nos. 10 and 15, respectively.
【0004】DFA類の味質については、イヌリンから
酵素的に生成させることができるDFAIおよびDFA
IIIが甘味を有することが知られている(特開昭63
−269962)。[0004] Regarding the taste quality of DFAs, DFAI and DFA which can be produced enzymatically from inulin.
III is known to have a sweet taste (JP-A-63
-269962).
【0005】肥満防止等の観点から、甘味剤としてはカ
ロリーがなるべく低いものが求められているのが現状で
ある。現在知られているノンカロリーの甘味を有する糖
質としては糖アルコールの一種であるエリスリトールだ
けである。この糖質は腸管からほとんどが吸収され、代
謝されずにそのまま尿中に排泄されるため、ノンカロリ
ーとされている。しかし、エリスリトールは溶解すると
き高い吸熱作用を示すので、食した際に口の中で冷涼感
を感じる。このため、冷涼感が好ましくない製品には使
用し難い場合があった。また、四炭糖の単糖であるた
め、氷菓に使用する際、氷点降下が大きすぎる問題もあ
った。甘味剤として使用されるマルチトールなど2糖類
の糖アルコールは消化酵素で分解されないが、腸内細菌
により有機酸に変換され、体内に吸収されるとして、2
kcal/g扱いとなっており、2糖類以上のノンカロ
リーの甘味を有する糖質は現在知られていない。[0005] From the viewpoint of prevention of obesity and the like, at present, sweeteners with as low a calorie as possible are required. Erythritol, a kind of sugar alcohol, is the only carbohydrate having a non-caloric sweetness known at present. Most of this carbohydrate is absorbed from the intestinal tract and excreted in urine as it is without being metabolized. However, erythritol exhibits a high endothermic effect when dissolved, so that it feels cool in the mouth when eaten. For this reason, it was sometimes difficult to use the product for which cooling sensation was not desirable. In addition, since it is a monosaccharide of tetracarbon sugar, there is a problem that the freezing point drop is too large when used in frozen desserts. Disaccharide sugar alcohols such as maltitol used as a sweetener are not decomposed by digestive enzymes, but are converted to organic acids by intestinal bacteria and absorbed into the body.
Carbohydrates treated as kcal / g and having non-caloric sweetness higher than disaccharides are not known at present.
【0006】[0006]
【発明が解決しようとする課題】上記したごとく、甘味
剤にはカロリーがなるべく低いものが現在一般に求めら
れている。多くの糖質が甘味を有するものとして知ら
れ、かつ使用されている。食品に糖質を添加する場合、
糖質の働きは、甘味等の味質を付与すること以外に、防
腐効果を与えたり(例えばシロップ、ジャム)、いわゆ
るボディ感(例えばケーキのボディ感)を与えたりする
ことが挙げられる。かかる観点から、食品の味質をあま
り変えずに、例えば甘味をあまり高めることなく、糖含
量を上げることが必要とされる場合がある。上記防腐効
果は、添加された糖質の溶液の水分活性に由来するの
で、かかる糖質としては水に対する溶解度が高いものが
好ましい。また、甘味剤をはじめ食品添加物は、一般に
熱や酸に安定で、食品中の他の物質との反応性の低いも
のが求められる。また、甘さを控えた食品は昨今の需要
の動向でもあり、通常の甘味剤、例えばショ糖の一部を
より低い甘味度の甘味剤で代替することも求められる。As described above, sweeteners that are as low in calories as possible are now generally required. Many sugars are known and used as having a sweet taste. When adding sugar to food,
The function of the saccharide is to impart a preservative effect (for example, syrup, jam) or a so-called body feeling (for example, a body feeling of a cake), in addition to imparting a taste such as sweetness. From such a viewpoint, it may be necessary to increase the sugar content without significantly changing the taste quality of the food, for example, without significantly increasing the sweetness. Since the preservative effect is derived from the water activity of the added saccharide solution, the saccharide preferably has high solubility in water. In addition, food additives such as sweeteners are generally required to be stable to heat and acids and have low reactivity with other substances in foods. In addition, the demand for sweetened foods is a trend of recent demand, and it is required to replace a part of a normal sweetener, for example, a part of sucrose with a sweetener of lower sweetness.
【0007】本発明はかかる需要に応えるもので、ノン
カロリーであるかカロリーがほとんどゼロに近く、非還
元性で反応性が低く、熱や酸、アルカリに対する安定性
に優れ、水に対する溶解度が高く、甘味度が低く、さら
に緩下作用のない特定糖質を含有する甘味剤等もしくは
その甘味付与等のための使用、および該特定糖質により
甘味付与等した飲食品もしくは薬品を提供することを目
的とする。The present invention meets this demand, and is non-caloric or almost zero in calories, non-reducing and low in reactivity, excellent in heat, acid and alkali stability, and high in water solubility. To provide a sweetener or the like containing a specific saccharide having a low degree of sweetness and further having no laxative action or its use for imparting sweetness and the like, and to provide a food or drink or a medicine imparted with a sweetness by the specific saccharide. Aim.
【0008】[0008]
【課題を解決するための手段】本発明は、ノンカロリー
であるかカロリーがほとんどゼロに近く、非還元性で安
定性に優れ、水に対する溶解度が高く、甘味度が低く、
下痢を引き起こしにくい糖質としての、以下の化学式で
表されるジ−β−D−フラクトフラノース1,2´:
2,1´ジアンヒドリド(以下、β−DFAという)を
有効成分として含有する甘味剤もしくは糖含量上昇剤、
または飲食品または薬品への甘味付与または糖含量上昇
のためのβ−DFAの使用に関する。本発明はさらに、
β−DFAを含有させることにより甘味を付与したまた
は糖含量を上昇させた飲食品または薬品に関する。DISCLOSURE OF THE INVENTION The present invention provides non-caloric or almost zero calorie, non-reducing and excellent stability, high solubility in water, low sweetness,
Di-β-D-fructofuranose 1,2 ′ represented by the following chemical formula as a carbohydrate that hardly causes diarrhea:
A sweetener or a sugar content increasing agent containing 2,1 ′ dianhydride (hereinafter referred to as β-DFA) as an active ingredient;
Alternatively, the present invention relates to the use of β-DFA for imparting sweetness to foods or drinks or medicines or increasing the sugar content. The invention further provides
The present invention relates to a food or drink or a medicine which is imparted with sweetness or has an increased sugar content by containing β-DFA.
【0009】[0009]
【化1】 Embedded image
【0010】なお、本願の特許請求の範囲における複数
の発明は、実質上同一発明の関係にあり、特許法第36
条第5項の規定により一出願での併記が認められる。上
記同一発明に関しては、社団法人発明協会発行の渡邉睦
雄著、「化学とバイオテクノロジーの特許明細書の書き
方読み方」(平成6年改訂版)の58頁に同一発明の例
として「Aからなるコンクリート強化混和剤」と「Aを
含む強化されたコンクリート製品」、および「Aからな
る防虫剤」と「Aを使用する防虫方法」と「Aで処理さ
れた防虫家具」の例が記載されている。Note that a plurality of inventions in the claims of the present application are substantially related to each other by the same invention.
According to the provisions of Paragraph 5 of the Article, concurrent writing in one application is permitted. Regarding the above-mentioned same invention, as an example of the same invention, “Concrete made of A” is described on page 58 of “How to Write a Patent Specification for Chemistry and Biotechnology” by Mutsuo Watanabe, published by the Japan Institute of Invention and Innovation. Examples of "reinforced admixtures" and "reinforced concrete products containing A", and "insect repellents consisting of A", "insect repellent methods using A", and "insect repellent furniture treated with A" are described. .
【0011】[0011]
【発明の実施の形態】以下に、本発明を詳細に説明す
る。その構造式から理解されるように、β−DFAは非
還元性であり、アミノ酸など食品中の他の物質との反応
性が低い。さらに、熱や酸、アルカリに対する安定性に
優れている。β−DFAの甘味度および水に対する溶解
度を、他の2糖類と比較して表1に示す。甘味度は5w
/v%または10w/v%のショ糖溶液を標準液とし
て、20℃で10人のパネラーで測定した。測定方法は
澱粉糖技術研究会報、第14号、p44(1956年)
に準じた。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. As understood from its structural formula, β-DFA is non-reducing and has low reactivity with other substances in foods such as amino acids. Furthermore, it is excellent in stability against heat, acid and alkali. The sweetness and solubility in water of β-DFA are shown in Table 1 in comparison with other disaccharides. Sweetness is 5w
The measurement was performed at 20 ° C. with 10 panelists using a sucrose solution of 10 / v% or 10 w / v% as a standard solution. Measuring method was reported by Starch Sugar Technology Research Association, No. 14, p44 (1956)
According to.
【0012】[0012]
【表1】 [Table 1]
【0013】表1からβ−DFAが水に対する溶解度が
非常に高いにもかかわらず、甘味度が約15と非常に低
い2糖類であることが理解され、これに上記安定性を加
味すると、β−DFAが食品の味質をあまり変えずに糖
含量を上げるのに非常に適した物質であることが理解さ
れる。From Table 1, it can be understood that β-DFA is a disaccharide having a very low degree of sweetness of about 15, despite its extremely high solubility in water. -It is understood that DFA is a very suitable substance for increasing the sugar content without significantly changing the taste quality of the food.
【0014】β−DFAの各種消化酵素による消化性に
ついて調べたところ、全く分解されなかった(実施例
1)。また、ラット小腸翻転サック法で腸管での吸収を
試験したが、吸収されなかった(実施例2)。また、大
腸における腸内細菌による資化性を調べた結果、どの菌
にも資化されなかった(実施例3)。また、糞便培養に
よる残存糖量を調べたところβ−DFAの減少は認めら
れなかった(実施例4)。さらに、β−DFAの最大無
作用量を調べたところ0.7g/kg体重以上であった
(実施例5)が、マルチトールは0.3g/kg体重で
あるので、緩下作用が極めて低い糖質であると理解でき
る。When the digestibility of β-DFA by various digestive enzymes was examined, it was not decomposed at all (Example 1). In addition, although absorption in the intestinal tract was tested by the rat small intestine inversion sac method, it was not absorbed (Example 2). In addition, as a result of examining the assimilation property of intestinal bacteria in the large intestine, none of the bacteria was assimilated (Example 3). In addition, when the amount of residual sugar by stool culture was examined, no decrease in β-DFA was observed (Example 4). Furthermore, when the maximum non-effective amount of β-DFA was examined, it was 0.7 g / kg body weight or more (Example 5). However, since maltitol was 0.3 g / kg body weight, the laxative effect was extremely low. It can be understood as a carbohydrate.
【0015】本発明の甘味剤もしくは糖含量上昇剤はβ
−DFAのみからなっていても良く、補助成分または他
の活性成分、例えば他の甘味成分と混合された形態にあ
っても良い。補助成分としては、水、常用される賦形剤
・結合剤等を用いることができる。賦形剤としては甘味
成分としても用いられるショ糖、乳糖、果糖、ソルビト
ール、マルチトール等の他、可溶性デンプン、デキスト
リン、ガム質マンナン、ペクチン、アルギン酸等の多糖
類、ゼラチン、低分子量ポリペプチド等のタンパク質、
炭酸カルシウム、リン酸カルシウム等の塩、クエン酸、
リンゴ酸、フマル酸等の酸等から適宜選択して用いるこ
とができる。結合剤としてはグアーガム、アラビアガ
ム、デキストリン等を必要に応じ適宜選択して用いるこ
とができる。その他、フレーバー、エッセンス、ビタミ
ン、調味料等を必要に応じ適宜選択して用いることがで
きる。他の甘味成分としては甘味付与に使用されるブド
ウ糖、果糖、ショ糖等の糖類、イソマルトオリゴ糖等の
オリゴ糖類、ソルビトール、マルチトール等の糖アルコ
ール、アスパルテーム、ステビオサイド、サッカリン等
を挙げることができる。また、他の呈味成分として酸
味、塩から味、渋味、旨味、苦味などを与える成分が挙
げられる。[0015] The sweetener or sugar content enhancer of the present invention is β
It may consist solely of DFA or may be in a form mixed with auxiliary or other active ingredients, for example other sweetening ingredients. As the auxiliary component, water, commonly used excipients / binders, and the like can be used. As an excipient, in addition to sucrose, lactose, fructose, sorbitol, maltitol, etc., which are also used as sweeteners, polysaccharides such as soluble starch, dextrin, gum mannan, pectin, alginic acid, gelatin, low molecular weight polypeptide, etc. Protein,
Salts such as calcium carbonate and calcium phosphate, citric acid,
It can be used by appropriately selecting from acids such as malic acid and fumaric acid. As the binder, guar gum, gum arabic, dextrin and the like can be appropriately selected and used as needed. In addition, flavors, essences, vitamins, seasonings and the like can be appropriately selected and used as needed. Examples of other sweet components include sugars such as glucose, fructose, and sucrose used for imparting sweetness, oligosaccharides such as isomaltooligosaccharide, sugar alcohols such as sorbitol and maltitol, aspartame, stevioside, and saccharin. . In addition, other taste components include components that impart a taste, astringency, umami, bitterness, and the like from sourness and salt.
【0016】本発明の甘味剤もしくは糖含量上昇剤は、
種々の形状で、例えば粉末、顆粒、シロップ等として用
いることができる。本甘味剤もしくは糖含量上昇剤のも
っとも通常の形態は濃厚水溶液(シロップ)である。The sweetener or sugar content enhancer of the present invention comprises
It can be used in various forms, for example, as powders, granules, syrups and the like. The most common form of the sweetener or sugar enhancer is a concentrated aqueous solution (syrup).
【0017】本発明の甘味剤もしくは糖含量上昇剤中の
β−DFAの含量は、飲食品や薬品に甘味を付与したり
糖含量を上昇させる効果を与えることができる含量であ
れば特に制限されないが、一般に5〜100w/w%が
好ましく、30〜100w/w%がさらに好ましく、5
0〜100w/w%がさらに一層好ましい。また、これ
とは別に本発明の甘味剤もしくは糖含量上昇剤が他の固
形成分(賦形剤、他の甘味剤等)を含有する場合、甘味
剤もしくは糖含量上昇剤全体としてのカロリーを低くし
または甘味度を低くするために、剤中に含まれるβ−D
FAと他の固形成分の合計量に対するβ−DFA量の割
合が、一般に与えられた順に好ましさが増すものとし
て、10、30、40、50、60または70w/w%
以上であることが好ましい。The content of β-DFA in the sweetener or sugar content enhancer of the present invention is not particularly limited as long as it can impart an effect of imparting sweetness to foods and drinks or medicines or increasing the sugar content. However, in general, 5 to 100 w / w% is preferable, 30 to 100 w / w% is more preferable, and 5 to 100 w / w% is more preferable.
0-100 w / w% is even more preferred. In addition, when the sweetener or the sugar-content increasing agent of the present invention contains other solid components (excipients, other sweeteners, etc.), the calorie of the sweetener or the sugar-content increasing agent as a whole is reduced. Β-D contained in the preparation to reduce the sweetness
The ratio of the amount of β-DFA to the total amount of FA and other solid components is generally 10, 30, 40, 50, 60 or 70 w / w% as the preference increases in the order given.
It is preferable that it is above.
【0018】本甘味剤もしくは糖含量上昇剤は、人およ
び他の動物によって摂取あるいは投与される飲食品また
は薬品の甘味付与および/または糖含量上昇のために広
く使用することができる。該飲食品の例としては、各種
調味料(例えば、醤油、味噌、マヨネーズ、ドレッシン
グ、天つゆ、ケチャップ、焼肉のタレ、カレールー、シ
チューの素、スープの素、ダシの素等)、各種和菓子
(例えば、煎餅、あられ、餅類、饅頭、ういろう、羊
羮、ゼリー、カステラ、飴玉等)、各種洋菓子(例え
ば、ビスケット、クラッカー、クッキー、パイ、プリ
ン、シュークリーム、スポンジケーキ、ドーナツ、チョ
コレート、チューインガム等)、パン類、氷菓子(例え
ば、アイスクリーム、シャーベット等)、シロップ類
(例えば、果実のシロップ漬等)、ペースト類(例え
ば、フルーツペースト、ピーナツペースト等)、ジャ
ム、マーマレード、漬物類(例えば、福神漬、千枚漬、
らっきょう漬等)、畜肉練り製品(例えば、ハム、ソー
セージ等)、魚肉練り製品(例えば、かまぼこ、竹輪
等)、各種珍味類、佃煮類、アルコール飲料、コーヒ
ー、ココア、ジュース、炭酸飲料、スタミナドリンク、
乳酸飲料、乳酸菌飲料、インスタント飲食品(例えば、
インスタントジュース、インスタントコーヒー等)等が
挙げられる。また、該薬品の例としては、散剤、錠剤、
水剤、シロップ剤などのほか、歯磨剤、含嗽剤等が挙げ
られる。The present sweetener or sugar content enhancer can be widely used for imparting sweetness and / or increasing the sugar content of foods, drinks or medicines ingested or administered by humans and other animals. Examples of the food and drink include various seasonings (for example, soy sauce, miso, mayonnaise, dressing, tempura, ketchup, grilled meat sauce, curry roux, stew ingredients, soup ingredients, dash ingredients, etc.), and various Japanese sweets (eg, , Rice crackers, hail, rice cakes, buns, uiro, sheep, jelly, castella, candy, etc., and various Western confectionery (eg, biscuits, crackers, cookies, pies, puddings, cream puffs, sponge cakes, donuts, chocolate, chewing gum, etc.) ), Breads, ice confectionery (eg, ice cream, sherbet, etc.), syrups (eg, fruit syrup pickles, etc.), pastes (eg, fruit paste, peanut paste, etc.), jams, marmalades, pickles (eg, , Fukujinzuke, Senmaizuke,
Rakikyo pickles, etc.), meat paste products (eg, ham, sausage, etc.), fish meat paste products (eg, kamaboko, bamboo rings, etc.), various delicacies, tsukudani, alcoholic beverages, coffee, cocoa, juice, carbonated beverages, stamina drinks,
Lactic acid drinks, lactic acid bacteria drinks, instant foods and drinks (for example,
Instant juice, instant coffee, etc.). Examples of the drug include powders, tablets,
In addition to solutions, syrups and the like, dentifrices, gargles and the like can be mentioned.
【0019】本甘味剤もしくは糖含量上昇剤の使用量に
ついては、対象の飲食品または薬品にとって甘味付与ま
たは糖含量上昇のために必要な程度まで任意に使用する
ことができる。具体的な使用量は飲食品または薬品によ
って異なるが、通常、本甘味剤もしくは糖含量上昇剤
が、本甘味剤もしくは糖含量上昇剤によって甘味を付与
したもしくは糖含量を上昇させた個々の飲食品または薬
品中において、β−DFAとして約0.5〜約85w/
w%、さらには約5.0〜約70w/w%の含量となる
ような範囲から選択するのが好ましい。The amount of the present sweetener or sugar content-increasing agent can be arbitrarily used to the extent necessary for imparting sweetness or increasing the sugar content for the food, drink or drug of interest. Although the specific amount used varies depending on the food or drink or the drug, it is usually the individual food or drink that the sweetener or sugar content enhancer imparts sweetness or the sugar content is increased by the sweetener or sugar content enhancer. Alternatively, in medicine, about 0.5 to about 85 w /
It is preferable to select from a range that gives a content of about 5.0% to about 70% w / w.
【0020】甘味付与および/または糖含量上昇のため
の対象品への本甘味剤もしくは糖含量上昇剤の使用方法
は通常の甘味剤と同様に行えば良い。例えば、飲食品類
または薬品類の製造時においてあるいはこれらの摂取時
において、混和、混捏、溶解、浸漬、浸透、散布、噴
霧、注入などの適宜の方法を採用して対象品類に含有せ
しめることができる。The method of using the present sweetener or the sugar content-increasing agent in a target product for imparting sweetness and / or increasing the sugar content may be performed in the same manner as a usual sweetener. For example, at the time of production of foods or beverages or medicines, or at the time of their ingestion, they can be incorporated into the target product by using an appropriate method such as mixing, kneading, dissolving, dipping, penetrating, spraying, spraying, or pouring. .
【0021】次にβ−DFAの製法について説明する。
70〜90w/w%の高濃度果糖水溶液をpH2.5〜
3.5、110〜150℃好ましくは130〜140
℃、大気圧下で1〜180分好ましくは20〜60分保
持することにより、DFA類がその約50w/w%を占
める縮合物を生成させ、ついで該処理液をpH2に調整
した後沸騰水浴中で30〜60分保持してDFA以外の
縮合物を果糖に分解する。ついで該処理液をNa型陽イ
オン交換樹脂カラムに通してDFA類の画分と果糖の画
分とを得る。DFA類の画分を逆相クロマトグラフイー
用カラムに通して各ピークを分離して、その中の1つの
ピーク画分としてβ−DFAの画分を得る。(参考例
1)。Next, a method for producing β-DFA will be described.
70-90% w / w% fructose aqueous solution with pH 2.5-
3.5, 110-150 ° C, preferably 130-140
C. and at atmospheric pressure for 1 to 180 minutes, preferably 20 to 60 minutes to form a condensate in which DFAs account for about 50% w / w, and then adjust the pH of the treatment solution to 2 before boiling water bath The mixture is kept for 30 to 60 minutes to decompose condensates other than DFA into fructose. Next, the treatment liquid is passed through a Na-type cation exchange resin column to obtain a fraction of DFAs and a fraction of fructose. The fractions of DFAs are passed through a column for reversed phase chromatography to separate each peak, and a β-DFA fraction is obtained as one of the peak fractions. (Reference Example 1).
【0022】[0022]
【実施例】次に本発明を実施例および参考例により具体
的に説明する。以下の実施例および参考例において濃度
を示す%は、別に規定する場合を除き、w/w%を表わ
す。実施例1 (β−DFAの各種消化酵素による分解性) 1)α−アミラーゼ 1%β−DFA(1mM CaClを含有する50mM
マレイン酸緩衝液、唾液アミラーゼ使用の場合pH6.
0で膵液アミラーゼ使用の場合pH6.9)1mlにヒ
ト唾液アミラーゼ(シグマ社製)、ブタ膵液アミラーゼ
(シグマ社製)をそれぞれ1単位添加し、37℃で2時
間反応させた後、残存率をHPLCで分析した。どちら
の酵素の場合もβ−DFAは99%以上残存していた。 *1単位は1%可溶性デンプンを基質として37℃で反
応させたとき、1分間に1μmolのグルコース相当の
還元力を生成する酵素量。Next, the present invention will be described specifically with reference to examples and reference examples. In the following Examples and Reference Examples,% indicating the concentration represents w / w%, unless otherwise specified. Example 1 (Degradability of β-DFA by various digestive enzymes) 1) α-amylase 1% β-DFA (50 mM containing 1 mM CaCl)
PH6 when maleic acid buffer or salivary amylase is used.
0 and the use of pancreatic amylase (pH 6.9), 1 unit of human salivary amylase (manufactured by Sigma) and 1 unit of porcine pancreatic amylase (manufactured by Sigma) were added to 1 ml each, and the mixture was reacted at 37 ° C. for 2 hours. Analyzed by HPLC. In each case, 99% or more of β-DFA remained. * 1 unit is the amount of enzyme that produces a reducing power equivalent to 1 μmol of glucose per minute when reacted at 37 ° C. using 1% soluble starch as a substrate.
【0023】2)胃酸 2%β−DFA水溶液1mlに対して、0.2M HC
l−KCl緩衝液(pH1.0、1.5、2.0)1m
lを加え、37℃で3時間反応させ、50mMNaOH
0.3mlを加えて反応を停止させ、残存率をHPL
Cで分析した。どのpHでもβ−DFAは99%以上残
存していた。 3)小腸粘膜局在酵素 ラット小腸アセトン粉末(シグマ社製)を生理食塩水に
懸濁(100mg/ml)し、ホモジナイズ後、遠心分
離した上清を酵素液として使用した。1%β−DFA
(25mMマレイン酸緩衝液(pH6.0))に酵素液
を1単位添加し、37℃で4時間反応させた後、残存率
をHPLCで分析したところ、β−DFAは99%以上
残存していた。 *1単位は1%マルトースを基質として37℃で反応さ
せたとき、1分間に1μmolのマルトースを分解する
酵素量。上記1)〜3)および後記実施例4におけるH
PLC条件は以下の通りであった。 カラム:YMC−Pack ODS−AQ(4.6×2
50mm)((株)ワイエムシイ製) 移動相:蒸留水 流速:0.5ml/min 検出:RI2) Stomach acid 0.2M HC per 1 ml of 2% β-DFA aqueous solution
1 m of l-KCl buffer (pH 1.0, 1.5, 2.0)
l, and reacted at 37 ° C. for 3 hours.
The reaction was stopped by adding 0.3 ml, and the remaining rate was determined by HPL.
Analyzed in C. At any pH, 99% or more of β-DFA remained. 3) Small intestinal mucosa localization enzyme Rat small intestine acetone powder (manufactured by Sigma) was suspended (100 mg / ml) in physiological saline, homogenized, and centrifuged, and the supernatant was used as an enzyme solution. 1% β-DFA
After adding 1 unit of the enzyme solution to (25 mM maleate buffer (pH 6.0)) and reacting at 37 ° C. for 4 hours, the residual ratio was analyzed by HPLC. As a result, 99% or more of β-DFA remained. Was. * 1 unit is the amount of enzyme that degrades 1 μmol maltose per minute when reacted at 37 ° C. using 1% maltose as a substrate. H in the above 1) to 3) and Example 4 described later.
The PLC conditions were as follows. Column: YMC-Pack ODS-AQ (4.6 × 2
50 mm) (manufactured by YMC) Mobile phase: distilled water Flow rate: 0.5 ml / min Detection: RI
【0024】実施例2 (β−DFAの腸管における消化・吸収性)ラットの翻
転小腸を用いて、消化・吸収性について検討した。4週
令のSD系雄性ラットを市販固形飼料CE−2(日本ク
レア)で約2週間飼育の後、1晩絶食して断頭屠殺、開
腹して胃幽門を起点として10cmと15cmの間の小
腸を取り出した。直ちに、取り出した長さ5cmの小腸
を裏返して、PBS(リン酸緩衝性生理食塩水)2ml
を封入し、両端を結紮して翻転小腸を作成した。14m
M濃度で調製したβ−DFA、マルトースまたはスクロ
ースのPBS溶液(PBSと等張になるようにPBSの
NaCl濃度を調節する)10mlを入れた試験管(内
径18mm)に翻転小腸を投入し、試験管内液にテフロ
ン細管で95v/v%酸素−5v/v%二酸化炭素混合
ガスを通気しながら20分静置した。なお、PBSおよ
び糖のPBS溶液はすべて37℃に保温して操作した。 Example 2 (Digestion and Absorption of β-DFA in the Intestinal Tract) Digestion and absorption were examined using the inverted small intestine of rats. After breeding 4-week-old male SD rats on the commercial solid feed CE-2 (CLEA Japan) for about 2 weeks, they are fasted overnight, sacrificed by decapitation, and laparotomized. Was taken out. Immediately, the small intestine having a length of 5 cm taken out was turned over, and 2 ml of PBS (phosphate buffered saline) was removed.
Was ligated, and the both ends were ligated to form a reversal small intestine. 14m
Invert the small intestine into a test tube (18 mm inner diameter) containing 10 ml of a PBS solution of β-DFA, maltose or sucrose prepared at M concentration (adjust the NaCl concentration of PBS so as to be isotonic with PBS). The solution in the test tube was allowed to stand still for 20 minutes while passing a mixed gas of 95 v / v% oxygen-5 v / v% carbon dioxide through a Teflon thin tube. The PBS and sugar solutions in PBS were all kept at 37 ° C. for operation.
【0025】試験管内液(粘膜側)および翻転小腸内腔
液(漿膜側)をそれぞれ回収して、沸騰水浴中で10分
間加熱して腸管組織から脱離した酵素を失活させた。両
液に定量的にグリセリンを加えて定容し、両性イオン交
換樹脂MB−3(オルガノ)により脱塩処理し、メンブ
レンフィルターで濾過し、高速液体クロマトグラフィー
でグリセリンを内部標準として糖組成を定量した。粘膜
側の溶液において、マルトースが38%、スクロースが
21%減少したのに対し、β−DFAの減少は2%と僅
かで、操作ロスの範囲内と考えられた。一方、漿膜側の
溶液において、マルトースおよびスクロースでは消化・
吸収によると考えられる単糖が増加したのに対し、β−
DFAでは単糖は検出されなかった。以上より、小腸で
マルトースおよびスクロースは消化・吸収されるのに対
して、β−DFAは消化・吸収されない可能性が示唆さ
れた。The test tube fluid (mucosal side) and the inverted small intestinal lumen fluid (serosa side) were collected, respectively, and heated in a boiling water bath for 10 minutes to inactivate the enzyme detached from the intestinal tissue. Glycerin is quantitatively added to both solutions to make a constant volume, desalted with amphoteric ion exchange resin MB-3 (organo), filtered through a membrane filter, and saccharide composition is determined by high performance liquid chromatography using glycerin as an internal standard. did. In the solution on the mucosal side, maltose was reduced by 38% and sucrose was reduced by 21%, whereas β-DFA was reduced by only 2%, which was considered to be within the range of operation loss. On the other hand, in the solution on the serosal side, maltose and sucrose
Monosaccharides, which are thought to be due to absorption, increased, while β-
No monosaccharide was detected by DFA. From the above, it was suggested that maltose and sucrose could be digested and absorbed in the small intestine, while β-DFA might not be digested and absorbed.
【0026】実施例3 (β−DFAの腸内細菌による資化性)寒天培地で培養
した新鮮な菌を、各糖液0.5%を含有するペプトン−
イースト−フィールドソリューション(PYF)培地に
各菌株が各々10CFU/チューブになるように接種
し、嫌気条件下、37℃で48時間培養し、対照として
用いたグルコース添加培地に対する発育度で資化性の判
定をした。その結果を示す表2から明らかなごとく、β
−DFAは調べた菌株のいずれにも資化されなかった。 Example 3 (Assimilation of β-DFA by intestinal bacteria) Fresh bacteria cultured on an agar medium were isolated from peptone containing 0.5% of each sugar solution.
Yeast-field solution (PYF) medium was inoculated with each strain at 10 CFU / tube, and cultured at 37 ° C. for 48 hours under anaerobic conditions. Judged. As is clear from Table 2 showing the results, β
-DFA was not assimilated by any of the strains examined.
【0027】[0027]
【表2】 [Table 2]
【0028】実施例4 (β−DFAの糞便培養における残存率)健康な成人男
子2名、女子2名の糞便をそれぞれ1回分全量採取し、
よく混合した。この内の3gを脱気したリン酸緩衝液
(pH6.8)27mlで希釈し、糞便溶液を作成し
た。これを6mlずつ2本に分注し、それぞれに6%β
−DFAまたは6%マルチトールを0.2ml添加し
た。その直後におよび嫌気的に6時間培養した後に、そ
の1.2mlを採取し、沸騰水浴中で5分処理した。こ
れを遠心分離(5,000g×10分)し、その上清1
mlを前処理用固相抽出カラムセップパックC18(ウ
ォーターズ社製)に通し、さらに水2.5mlで押し出
した。処理液をさらに両イオン交換樹脂MB−3(オル
ガノ社製)で脱塩後、5mlにメスアップし、メンブラ
ンフイルターでろ過し、HPLCで分析した。培養前後
の糖量を比較した結果、マルチトールでは42w/w%
の残存率であったのに対し、β−DFAでは97w/w
%の残存率であった。 Example 4 (Residual rate of β-DFA in stool culture) The feces of two healthy adult males and two females were collected once each,
Mix well. 3 g of this was diluted with 27 ml of degassed phosphate buffer (pH 6.8) to prepare a fecal solution. This was dispensed into two tubes of 6 ml each, and 6% β
-0.2 ml of DFA or 6% maltitol was added. Immediately thereafter and after anaerobic cultivation for 6 hours, 1.2 ml thereof was collected and treated in a boiling water bath for 5 minutes. This was centrifuged (5,000 g × 10 minutes), and the supernatant 1
The mixture was passed through a pretreatment solid-phase extraction column Sepp C18 (manufactured by Waters), and further extruded with 2.5 ml of water. The treated solution was further desalted with both ion-exchange resins MB-3 (manufactured by Organo Corporation), and then made up to 5 ml, filtered through a membrane filter, and analyzed by HPLC. As a result of comparing the amount of sugar before and after the culture, it was found that maltitol had 42 w / w%.
Was 97% w / w with β-DFA.
% Residual rate.
【0029】実施例5 (β−DFAの健常人における最大無作用量)健康な成
人男子ボランティア、各群3名に、食後3時間後に、β
−DFAを含有する水溶液をβ−DFAとしてそれぞれ
0.3、0.5および0.7g/kg体重ずつ飲水とし
て投与した。どの群でも下痢を生じた者はいなかった。
したがって、最大無作用量は0.7g/kg体重以上と
考えられる。 Example 5 (Maximum no-effect level of β-DFA in healthy volunteers) Three healthy adult male volunteers were treated with β
Aqueous solutions containing -DFA were administered as drinking water at 0.3, 0.5 and 0.7 g / kg body weight, respectively, as β-DFA. No diarrhea occurred in any group.
Therefore, the maximum no-effect level is considered to be 0.7 g / kg body weight or more.
【0030】実施例6 甘味剤製剤例1 β−DFAシロップ(水分25%)50gとマルチトー
ルシロップ(水分25%)50gとを混合して低甘味甘
味剤を調製した。本甘味剤は甘味度25であるが、ショ
糖と同様に非還元性であり、ショ糖と同様な水分活性や
浸透圧を有していた。 Example 6 Sweetener Preparation Example 1 A low sweetener was prepared by mixing 50 g of β-DFA syrup (25% moisture) and 50 g of maltitol syrup (25% moisture). This sweetener had a degree of sweetness of 25, but was non-reducing similarly to sucrose, and had water activity and osmotic pressure similar to sucrose.
【0031】実施例7 甘味剤製剤例2 β−DFAシロップ(水分25%)50gとα−グリコ
シルステビア甘味物0.13gとを混合して甘味剤を調
製した。本甘味剤は甘味度50であるが、ショ糖と同様
に非還元性であり、ショ糖と同様な水分活性や浸透圧を
有していた。 Example 7 Preparation of Sweetener Example 2 A sweetener was prepared by mixing 50 g of β-DFA syrup (25% moisture) and 0.13 g of α-glycosylstevia sweetener. This sweetener had a sweetness of 50, but was non-reducing similarly to sucrose, and had water activity and osmotic pressure similar to sucrose.
【0032】実施例8 飲食物への添加例1(ジャムへ
の利用) カットしたイチゴ60g、実施例6で調製した甘味剤1
40g、ペクチン0.7gおよびクエン酸0.4gを混
合して加熱し、糖濃度65%まで煮詰めて製品とした。
低甘味で素材の味がそのまま活かされた今までにないジ
ャムであった。 実施例9 飲食物への添加例2(練り飴への利用) 生飴100g、ショ糖50g、実施例6で調製した甘味
剤50g、食塩0.6gおよび水50gを混合して加熱
し、水分30%まで練り上げて製品とした。甘さが抑え
られ素材の風味が活きた、淡い色合いの艶が良い練り飴
であった。[0032]Example 8 Addition example 1 to food and drink (to jam
Utilization) 60 g of cut strawberry, sweetener 1 prepared in Example 6
40 g, 0.7 g of pectin and 0.4 g of citric acid
The mixture was heated and boiled down to a sugar concentration of 65% to obtain a product.
Unprecedented di
It was jam. Example 9 Addition Example 2 to Foods and Drinks (Utilization for Pastry) 100 g of raw candy, 50 g of sucrose, sweetness prepared in Example 6
Mix 50g of agent, 0.6g of salt and 50g of water and heat
And kneaded to a moisture of 30% to obtain a product. Less sweetness
A light-colored, glossy paste that takes advantage of the flavor of the ingredients
Met.
【0033】実施例10 薬品への添加例(歯磨剤への
利用) リン酸カルシウム2水和物50g、グリセリン10g、
実施例7で調製した甘味剤13g、ラウリル硫酸ナトリ
ウム2.5g、スペアミントオイル1.5g、トラガン
トガム1.0gおよび水22gを混合して製品とした。
本品は刺激的な甘味がなく、柔らかなミントフレーバー
を有していた。 Example 10 Examples of Addition to Chemicals (Usage to Dentifrice) 50 g of calcium phosphate dihydrate, 10 g of glycerin,
A product was prepared by mixing 13 g of the sweetener prepared in Example 7, 2.5 g of sodium lauryl sulfate, 1.5 g of spearmint oil, 1.0 g of tragacanth gum and 22 g of water.
The product had no irritating sweetness and had a soft mint flavor.
【0034】参考例1 果糖の縮合によるβ−DFAの
製造 果糖150gを40gの水に溶解し、10%クエン酸溶
液0.6mlを添加した。これをミキサーで攪拌しなが
ら、電熱器で加熱し、水分を蒸発させながら130℃〜
140℃で20分反応させた。反応物を糖濃度50%程
度になるように水で希釈し、塩酸でpH2に調整した
後、沸騰水浴中で30分処理してDFA(ジフラクトー
スジアンヒドリド)以外の縮合物を分解した。これをN
a型強酸性陽イオン交換樹脂(三菱化学(株)製UBK
−530、樹脂量11.8L)により分離し、β−DF
A含有(5%)画分を固形分として35g得た。つい
で、この溶液を50%濃度に濃縮し、5gずつ逆相クロ
マトグラフィー用カラム((株)ワイエムシイ製YMC
−Pack ODS−AQ、10×100cm×2本)
に負荷し、移動相として脱塩水を用い、250ml/分
の流速で通液し、分画分取を行い、得られた水溶液を減
圧濃縮して98%純度のβ−DFAの75%水溶液(シ
ロップ)2gを得た。得られたβ−DFAの比旋光度お
よびC−NMRケミカルシフトは以下の通りであった。 比旋光度[α]:−80 C−NMRケミカルシフト:100.7(C−2)、
(81.6、79.4、74.9)(C−3、C−4、
C−5)、(63.7、62.6)(C−1、C−6) Reference Example 1 Production of β-DFA by Condensation of Fructose 150 g of fructose was dissolved in 40 g of water, and 0.6 ml of a 10% citric acid solution was added. While stirring this with a mixer, heat it with an electric heater, and evaporate
The reaction was performed at 140 ° C. for 20 minutes. The reaction product was diluted with water to a sugar concentration of about 50%, adjusted to pH 2 with hydrochloric acid, and then treated in a boiling water bath for 30 minutes to decompose condensates other than DFA (difructose dianhydride). This is N
a-type strongly acidic cation exchange resin (UBK manufactured by Mitsubishi Chemical Corporation)
-530, resin amount 11.8 L).
35 g of an A-containing (5%) fraction was obtained as a solid content. Then, this solution was concentrated to a concentration of 50%, and a column for reverse phase chromatography (YMC manufactured by YMC)
-Pack ODS-AQ, 10 x 100 cm x 2)
, And the solution was passed through at a flow rate of 250 ml / min using demineralized water as a mobile phase, fractionated and fractionated. 2 g of syrup) were obtained. The specific rotation and C-NMR chemical shift of the obtained β-DFA were as follows. Specific rotation [α]: -80 C-NMR chemical shift: 100.7 (C-2),
(81.6, 79.4, 74.9) (C-3, C-4,
C-5), (63.7, 62.6) (C-1, C-6)
【0035】[0035]
【発明の効果】本発明の甘味剤もしくは糖含量上昇剤
は、ノンカロリーであるかカロリーがほとんどゼロに近
く、非還元性で安定性に優れ、水に対する溶解度が高
く、甘味度が低く、さらに緩下作用のない糖質であるβ
−DFAを有効成分としているので、ノンカロリー甘味
剤として、糖含量上昇剤として、また下痢を引き起こし
にくい安定な甘味剤として有用である。かかる甘味剤も
しくは糖含量上昇剤は飲食品もしくは薬品への甘味付与
または糖含量上昇のために用いることができる。The sweetener or sugar content enhancer of the present invention is non-caloric or almost zero in calories, is non-reducing, has excellent stability, has high solubility in water, has low sweetness, Β, a carbohydrate with no laxative effect
-Since DFA is used as an active ingredient, it is useful as a non-caloric sweetener, as a sugar content increasing agent, and as a stable sweetener that hardly causes diarrhea. Such a sweetener or a sugar content-increasing agent can be used for imparting sweetness to a food or drink or a drug or for increasing the sugar content.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 弥武 経也 千葉県船橋市日の出2−20−2昭和産業株 式会社総合研究所内 ────────────────────────────────────────────────── ─── Continuing from the front page (72) Inventor Tetsuya Yatake 2-20-2 Hinode, Funabashi-shi, Chiba Pref.
Claims (4)
´:2,1´ジアンヒドリド(以下、特許請求の範囲の
記載においてβ−DFAという)を有効成分として含有
する甘味剤または糖含量上昇剤。1. Di-β-D-fructofuranose 1,2
': A sweetener or a sugar content-increasing agent containing 2,1' dianhydride (hereinafter referred to as β-DFA in the claims) as an active ingredient.
含量上昇のためのβ−DFAの使用。2. Use of β-DFA for imparting sweetness to foods or drinks or medicines or increasing the sugar content.
を付与したまたは糖含量を上昇させた飲食品。3. A food or drink having a sweet taste or an increased sugar content by containing β-DFA.
を付与したまたは糖含量を上昇させた薬品。4. A drug imparted with sweetness or increased sugar content by containing β-DFA.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10013238A JPH11155520A (en) | 1997-09-29 | 1998-01-08 | Use for sweetening, etc. or sweetening, etc., and foods and drinks or drugs with sweetening, etc. |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9-281336 | 1997-09-29 | ||
JP28133697 | 1997-09-29 | ||
JP10013238A JPH11155520A (en) | 1997-09-29 | 1998-01-08 | Use for sweetening, etc. or sweetening, etc., and foods and drinks or drugs with sweetening, etc. |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11155520A true JPH11155520A (en) | 1999-06-15 |
Family
ID=26349010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10013238A Pending JPH11155520A (en) | 1997-09-29 | 1998-01-08 | Use for sweetening, etc. or sweetening, etc., and foods and drinks or drugs with sweetening, etc. |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11155520A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003090759A1 (en) * | 2002-04-26 | 2003-11-06 | Fancl Corporation | Difructose anhydride-containing composition and use thereof |
JP2005008616A (en) * | 2003-05-29 | 2005-01-13 | Showa Sangyo Co Ltd | Immunostimulator |
WO2003020054A3 (en) * | 2001-08-31 | 2007-11-29 | Nordzucker Ag | Beverage with storage-stable dietary fiber additive |
WO2008081795A1 (en) * | 2006-12-28 | 2008-07-10 | Fancl Corporation | Method for production of dfa iii and plant extract having high dfa iii content |
US8048866B2 (en) | 2004-08-13 | 2011-11-01 | Nippon Beet Sugar Mfg., Co., Ltd. | Preventive and/or therapeutic agent for calcipenia |
JP5688628B1 (en) * | 2014-08-05 | 2015-03-25 | 聖一 村上 | Methods for improving the flavor and quality of foods and food flavor and quality improvers |
WO2023089335A1 (en) * | 2021-11-19 | 2023-05-25 | Tate & Lyle Solutions Usa Llc | Sweetener composition |
-
1998
- 1998-01-08 JP JP10013238A patent/JPH11155520A/en active Pending
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003020054A3 (en) * | 2001-08-31 | 2007-11-29 | Nordzucker Ag | Beverage with storage-stable dietary fiber additive |
WO2003090759A1 (en) * | 2002-04-26 | 2003-11-06 | Fancl Corporation | Difructose anhydride-containing composition and use thereof |
US7754701B2 (en) | 2002-04-26 | 2010-07-13 | Fancl Corporation | Difructose anhydride-containing composition and use thereof |
US7964581B2 (en) | 2002-04-26 | 2011-06-21 | Fancl Corporation | Use of difructose anhydride-containing composition |
US8492363B2 (en) | 2002-04-26 | 2013-07-23 | Fancl Corporation | Use of difructose anhydride-containing composition |
JP2005008616A (en) * | 2003-05-29 | 2005-01-13 | Showa Sangyo Co Ltd | Immunostimulator |
US8048866B2 (en) | 2004-08-13 | 2011-11-01 | Nippon Beet Sugar Mfg., Co., Ltd. | Preventive and/or therapeutic agent for calcipenia |
WO2008081795A1 (en) * | 2006-12-28 | 2008-07-10 | Fancl Corporation | Method for production of dfa iii and plant extract having high dfa iii content |
JP2008162974A (en) * | 2006-12-28 | 2008-07-17 | Fancl Corp | Method for producing dfaiii and dfaiii-rich plant extract |
JP5688628B1 (en) * | 2014-08-05 | 2015-03-25 | 聖一 村上 | Methods for improving the flavor and quality of foods and food flavor and quality improvers |
JP2016036265A (en) * | 2014-08-05 | 2016-03-22 | 聖一 村上 | Method for improving flavor/quality of food and food flavor/quality improver |
WO2023089335A1 (en) * | 2021-11-19 | 2023-05-25 | Tate & Lyle Solutions Usa Llc | Sweetener composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11653685B2 (en) | D-psicose-containing sweetener and foods and drinks and the like obtained by using same | |
JP2919851B2 (en) | Use of fructosyl oligosaccharides as low calorie sweeteners and food or dietary products or beverages containing them | |
EP1210880B1 (en) | Compositions containing sucralose and application thereof | |
US20080220140A1 (en) | Use of propenylphenyl glycosides for enhancing sweet sensory impressions | |
JPS63126469A (en) | Low calorie carbohydrate sweetener and d- tagatose as extender | |
AU2004216397B2 (en) | New use of polydextrose in edible products, edible products containing polydextrose and process for including polydextrose in edible products | |
JPS646752B2 (en) | ||
JP2004073197A (en) | Sweetening composition and food containing the same | |
JP2002045145A (en) | Sweetener composition and method for producing the same | |
KR20200021525A (en) | Intraoral Sweetener Compositions and Methods | |
JP2002034501A (en) | Sweetening composition and low calorie drinks | |
JP2018024619A (en) | Endurance improver | |
JPH0383557A (en) | Production of food and drink or the like | |
JPH11155520A (en) | Use for sweetening, etc. or sweetening, etc., and foods and drinks or drugs with sweetening, etc. | |
JP2002223721A (en) | Taste improver, method for improving taste and sweetener composition | |
JP2001258502A (en) | Sweetener composition, method for imparting sweetness and its use | |
JP7217089B2 (en) | Blood sugar elevation inhibitor and oral composition containing the same | |
JP2005151925A (en) | Sweetener composition and food and drink containing the same | |
JPS647752B2 (en) | ||
JP3020583B2 (en) | Method for removing bitterness of β-glucooligosaccharide | |
JPH11103814A (en) | Bitterness, taste improver, use for imparting bitterness or improving taste, and food or drink or medicine imparted with bitterness or improved taste | |
JP3681193B2 (en) | α-Isomaltosyl α-isomaltoside, production method thereof and use | |
AU2017411570B2 (en) | Sweetener composition and method for improving taste of stevia extract | |
JPH10234331A (en) | High quality sweetener taste improver and its use | |
JP2021023219A (en) | Masking agent for protein |